ANONYMOUS: "Amgen presents denosumab and sclerostin antibody data at American Society for Bone and Mineral Research Annual Meeting", AMGEN MEDIA PRESS RELEASE, 2006, pages 1-3, XP002517455, Retrieved from the Internet: URL:www.amgen.com/media/media_pr_detail.js p?releaseID=907028 [retrieved on 2009-02-26] (B1)

MCCLUNG M R ET AL: "Romosozumab in postmenopausal women with low bone mineral density", THE NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, US, vol. 370, no. 5, 1 January 2014 (2014-01-01), pages 412-420, XP009178243, ISSN: 0028-4793, DOI: 10.1056/NEJMOA1305224 (B1)

MICHAEL S OMINSKY ET AL: "Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength", JOURNAL OF BONE AND MINERAL RESEARCH, vol. 25, no. 5, 1 May 2010 (2010-05-01), pages 948-959, XP055037140, ISSN: 0884-0431, DOI: 10.1002/jbmr.14 (B1)

WO-A2-2006/119107 (B1)

PADHI ET AL: "Anti-sclerostin antibody increases markers of bone formation in healthy postmenopausal women", Oasis, Online Abstract Submission and Invitation System, 18 September 2007 (2007-09-18), page 1, XP002517555, Retrieved from the Internet: URL:www.abstractsonline.com/viewer/SearchR esults.asp [retrieved on 2009-03-03] (B1)

PADHI ET AL: "OC35 - Effects of anti-sclerostin monoclonal antibody in healthy postmenopausal women", OSTEOPOROSIS INTERNATIONAL / SUPPLEMENT 1, vol. 19, 20 March 2008 (2008-03-20), page S19, XP002517556, (B1)

WARMINGTON K ET AL: "SCIEROSTIN ANTAGONISM IN ADULT RODENTS, VIA MONOCLONAL ANTIBODY MEDIATED BLOCKADE, INCREASES BONE MINERAL DENSITY AND IMPLICATES SCLEROSTIN AS A KEY REGULATOR OF BONE MASS DURING ADULTHOOD", JOURNAL OF BONE AND MINERAL RESEARCH, BLACKWELL SCIENCE, INC, US, vol. 19, 5 October 2004 (2004-10-05), page S56, XP009072609, ISSN: 0884-0431, DOI: 10.1359/JBMR.0301211 (B1)

PADHI ET AL: "Anti-sclerostin antibody increases markers of bone formation in healthy postmenopausal women", JOURNAL OF BONE AND MINERAL RESEARCH, vol. 22 (Suppl. 1), September 2007 (2007-09), page S37, XP002689215, (B1)